Lupus Nephritis Clinical Trials Near Me
As of October 12, 2026, 101 Lupus Nephritis clinical trials are recruiting or about to open (75 recruiting now, 26 opening soon). 29 of them have at least 1 open site in the United States, across 35 states. Enter your ZIP code to see which are closest to you.
Also on Trial Friend:Lupus Nephritis pageMatch Me
All 75 Lupus Nephritis trials and their US sites
Enter your ZIP code above to sort them by how far their nearest open site is from you.
- PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus NephritisPurushotham & Akther Kotha MD, Inc., La Mesa, California; Valerius Medical Group & Research Center of Greater Long Beach, Inc., Los Alamitos, California; Western Nephrology & Metabolic Bone Disease, PC, Arvada, Colorado and 24 more sitesRecruitingPhase 4Ages 18 to 75Run by Aurinia Pharmaceuticals Inc.
- Lupus Landmark Study: A Prospective Registry and BiorepositoryUniversity of Alabama at Birmingham, Birmingham, Alabama; University of Arizona, Tucson, Arizona; Wallace Rheumatic Studies Center, Beverly Hills, California and 16 more sitesRecruitingAges 18 to 110Run by Lupus Research Alliance
- The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) StudyUniversity of California, San Francisco, San Francisco, California; Children's Hospital Colorado, Aurora, Colorado; Emory Children's Center, Atlanta, Georgia and 16 more sitesRecruitingPhase 2Ages 8 to 20Run by Children's Hospital Medical Center, Cincinnati
- RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus ErythematosusUniversity of California Irvine, Orange, California; UC Davis Health, Sacramento, California; Mayo Clinic, Jacksonville, Florida and 15 more sitesRecruitingPhase 1/2Ages 12 to 65Run by Cabaletta Bio
- A Phase 1 Study of FT819 in B-cell Mediated Autoimmune DiseaseWallace Rheumatic Center, Beverly Hills, California; Providence Medical Foundation, Fullerton, California; University of California Irvine, Irvine, California and 13 more sitesRecruitingPhase 1Ages 12 to 70Run by Fate Therapeutics
- A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)16 open sitesRecruitingPhase 1/2Ages 18 to 75Run by Nkarta, Inc.
- VIBRANT: VIB4920 for Active Lupus NephritisUniversity of California San Diego School of Medicine: Division of Rheumatology, Allergy and Immunology, La Jolla, California; UCLA Medical Center: Division of Rheumatology, Los Angeles, California; of California, Irvine School of Medicine Division of Rheumatology, Orange, California and 13 more sitesRecruitingPhase 2Ages 18+Run by National Institute of Allergy and Infectious Diseases (NIAID)
- A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular TreatmentDolphin Medical Research, Doral, Florida; Alloy Clinical Research LLC, Kissimmee, Florida; SouthCoast Research Center, Miami, Florida and 10 more sitesRecruitingPhase 3Ages 18 to 75Run by Viatris Innovation GmbH
- A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus NephritisWallace Rheumatic Studies Center, Beverly Hills, California; Kaiser Permanente Fontana, Fontana, California; Providence Medical Foundation, Fullerton, California and 9 more sitesRecruitingPhase 2Ages 12 to 70Run by Fate Therapeutics
- Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- VRonald Reagan UCLA Medical Center, Los Angeles, California; University of Colorado Denver, Aurora, Colorado; Royal Research Corp, Hollywood, Florida and 9 more sitesRecruitingPhase 2Ages 18 to 100Run by Novartis Pharmaceuticals
- A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune DiseaseUC San Diego Health, La Jolla, California; Stanford University Medical Center, Redwood City, California; Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois and 6 more sitesRecruitingPhase 1Ages 18 to 70Run by CRISPR Therapeutics
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric ParticipantsLoma Linda University health, Loma Linda, California; UCSF Benioff Childrens Hospital, San Francisco, California; Children's Hospital Colorado, Anchutz Medical Campus, Aurora, Colorado and 6 more sitesRecruitingPhase 2Ages 5 to 17Run by Hoffmann-La Roche
- Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy TrialAARA Clinical Research, Glendale, Arizona; Piedmont Physicians Rheumatology, Atlanta, Georgia; Georgia Nephrology Research Institute, Lawrenceville, Georgia and 4 more sitesRecruitingPhase 4Ages 18 to 80Run by NephroNet, Inc.
- A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus NephritisUniversity of Chicago, Chicago, Illinois; New York Medical College, Hawthorne, New York; NorthWell, New Hyde Park, New York and 1 more siteRecruitingPhase 2Ages 16 to 70Run by iCell Gene Therapeutics
- Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN4 open sitesRecruitingAges 18+Run by GlaxoSmithKline
- A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G3 open sitesRecruitingPhase 2Ages 16+Run by Akebia Therapeutics
- Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus NephritisUniversity of California San Francisco - Zuckerberg San Francisco General, San Francisco, California; Mayo Clinic, Rochester, Minnesota; Baylor College of Medicine, Houston, TexasRecruitingPhase 1Ages 18 to 60Run by Regeneron Pharmaceuticals
- Obe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)Icahn School of Medicine at Mount Sinai, New York, New York; State University of New York Upstate Medical Center (SUNY), Syracuse, New York; Texas Transplant Institute, San Antonio, TexasRecruitingPhase 2Ages 12 to 65Run by Autolus Limited
- Dapagliflozin in Active Lupus NephritisMassachusetts General Hospital, Boston, Massachusetts; Brigham and Women's Hospital, Boston, MassachusettsRecruitingPhase 4Ages 18 to 70Run by Brigham and Women's Hospital
- Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune DisordersMD Anderson Cancer Center, Houston, Texas; The University of Texas Health Science Center at Houston, Houston, TexasRecruitingPhase 1/2Ages 18+Run by M.D. Anderson Cancer Center
New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.
You'll get new recruiting trials, changes to trials, FDA decisions and condition news for Lupus Nephritis. Turn any of these off from the link in every email.
Where Lupus Nephritis trials are recruiting in the US
The US cities with the most Lupus Nephritis trials recruiting are Atlanta, Georgia (8), Houston, Texas (8), New York, New York (8), Chicago, Illinois (7) and Philadelphia, Pennsylvania (6), counting trials with at least 1 open site in each city.
Hospitals that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Lupus Nephritis, even if no trial fits you.
- Emory Children's Center
- Emory University
- Emory University School of Medicine: Division of Rheumatology
- and 2 more
- Baylor College of Medicine
- Baylor College of Medicine Pediatric Immunology Allergy Rheumatology
- MD Anderson Cancer Center
- and 6 more
- Hospital for Special Surgery
- Children's Hospital at Montefiore
- Columbia University Medical Center
- and 6 more
- University of Chicago
- Ann & Robert H. Lurie Children's Hospital of Chicago
- Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center
- and 4 more
- Children's Hospital of Philadelphia
- Children's Hospital of Philadelphia - Accepting Young Adult and Adolescent Patients
- Fox Chase Cancer Center- Temple BMT
- and 3 more
- University of California San Francisco
- UCSF Benioff Childrens Hospital
- University of California San Francisco - Zuckerberg San Francisco General
- and 2 more
- Brigham and Women's Hospital
- Massachusetts General Hospital
- Boston Children's Hospital - Accepting Young Adult and Adolescent Patients
- and 3 more
- Nicklaus Children's Hospital
- Allied Biomedical Research Institute
- DH NationalResearchCenters INC
- and 5 more
States with at least 1 open site: Alabama, Arizona, Arkansas, California, Colorado, District of Columbia, Florida, Georgia, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, Nevada, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, Washington, Wisconsin.
Questions about finding a Lupus Nephritis trial near you
Are there Lupus Nephritis clinical trials near me?
As of October 12, 2026, 101 Lupus Nephritis clinical trials are recruiting or about to open (75 recruiting now, 26 opening soon). 29 of them have at least 1 open site in the United States, across 35 states. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.
Which states have Lupus Nephritis clinical trial sites?
As of October 12, 2026, recruiting Lupus Nephritis trials list open sites in 35 states. The US cities with the most Lupus Nephritis trials recruiting are Atlanta, Georgia (8), Houston, Texas (8), New York, New York (8), Chicago, Illinois (7) and Philadelphia, Pennsylvania (6), counting trials with at least 1 open site in each city.
What if there is no Lupus Nephritis trial near me?
Some trials pay for or reimburse travel and lodging, and a few send staff or use local labs so fewer visits happen at the study site, so ask the study contact before ruling a trial out. You can also sign up on this page to get an email when a Lupus Nephritis trial opens a new site or changes status.
How is the distance to a trial site measured?
Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.
FDA-approved for Lupus Nephritis: Lupkynis (voclosporin), Benlysta (belimumab), Gazyva (obinutuzumab).
Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of October 12, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out.